((45_cluster_WAC1376cluster143|5ab31d|0-320|5834|WAC1376cluster143_2250_0493:0.003856183,(44_cluster_WAC1375|eaf231|0-320|5649|WAC1375_2139_0493:0.000000006,46_cluster_WAC1416cluster068|31c0c3|0-320|5983|WAC1416cluster068_2316_0493:0.003247781)0.928:0.022677596)1.000:0.272853143,(01_cluster_A40926|9e3e56|0-319|32|A40926_32_0493:0.092218720,28_cluster_NcoxDSM45129|48a3b6|0-319|3678|NcoxDSM45129_1504_0493:0.056437021)0.998:0.098533925,(48_cluster_WAC1424cluster109|e5969c|0-319|6296|WAC1424cluster109_2472_0493:0.130674475,(21_cluster_esnapd15|42e511|0-326|2781|esnapd15_1093_0493:0.175031493,(37_cluster_Teicoplanin|d459fe|0-323|4805|Teicoplanin_1834_0493:0.006538713,38_cluster_Teicoplanin2|a73b85|0-323|4935|Teicoplanin2_1885_0493:0.000000005)1.000:0.135085311)0.939:0.061443616)0.721:0.060395869);
